Annual Prevalence of Geographic Atrophy and Wet Age-Related Macular DeGeneration Among Medicare Advantage Enrollees in a US Health Plan

By: Vishal Saundankar, BPharm, MS, Mark Borns, PharmD, Kelly Broderick, PharmD, Birva Shah, OD, Stuart Cowburn, MS, Steven McFadden, PharmD, and Brandon Suehs, PharmD, PhD

Man at optometrist's office getting consultation talking to doctor with tablet

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD) that can lead to visual impairment. Published studies estimate approximately 1 million people in the United States have GA in at least 1 eye. There is a lack of real-world evidence from the US payer perspective on the prevalence of AMD and GA among Medicare Advantage prescription drug (MAPD) plan enrollees.